2012 Request for Applications: Clinician-Scientist Program

1. Program Objective

This Request for Applications (RFA) is intended to support research for Clinician-Scientists initiating a career as an investigator/junior faculty in prostate cancer research.

2. Mechanisms of Support

  • The Clinician-Scientist Award has a length of 2 years and a value of $150,000/year

3. Program Eligibility

In order to apply for this award, applicants must:

  • have five years or less of service as an independent investigator within the area of prostate cancer research
  • possess an M.D. degree or equivalent
  • be licensed to practice medicine in Canada
  • be nominated by a hospital-affiliated research institution
  • candidates who are currently in training must start as faculty in July 2012 in order to be eligible to apply

4. Applications

To apply, applicants must fill out an online application form which will be found on the Prostate Cancer Canada website on January 3, 2012.

5. Important Dates

Competition Opens: January 3, 2012

Applications Deadline: March 15, 2012 at 5p.m. EST

Notice of Decision: June 29, 2012

Funding Start Date: July 3, 2012

6. Contact

Joanne Reynolds
joanne.reynolds@prostatecancer.ca
Prostate Cancer Canada 
2 Lombard Street, 3rd Floor
Toronto, Ontario, M5C 1M1
416-441-2131 Ext.  226
1-888-255-0333
www.prostatecancer.ca

Plaid for Dad


Subscribe to our free monthly e-newsletter!

* indicates required

 





 
PCC Spotlight
Honouring dad this Father’s Day the Canadian way: In plaid

TORONTO, ON – (May 8, 2018) – Plaid replaces business-casual on Friday, June 15 as hundreds of thousands of Canadians don the iconic Canadian attire all to honour dad and end prostate cancer.
More

The Finger – A tried and true method to save lives

TORONTO, CANADA (May 8, 2018) – Every day, more and more methods to detect prostate cancer are being explored, but the tried and true methods of a digital rectal examination (DRE) – where a healthcare professional inserts a gloved finger into the rectum to check for abnormalities, paired with a blood test known as the prostate-specific antigen (PSA) test – which you can get through your family doctor, are still the long-standing proven ways to save a life.
More

Landmark study links tumour evolution to prostate cancer severity

Toronto (April 19, 2018) – Findings from Canadian Prostate Cancer Genome Network (CPC-GENE) researchers and their collaborators, published today in Cell, show that the aggressiveness of an individual prostate cancer can be accurately assessed by looking at how that tumour has evolved.
More


Click here for news archive